Pactiv Evergreen (PTVE) PT Raised to $13 at RBC Capital
Tweet
Share
E-mailGet Alerts PTVE Hot Sheet
Price: $18.01 --0%
Rating Summary:
5 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 19
Rating Summary:
5 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 19
Join SI Premium – FREE
RBC Capital analyst Arun Viswanathan raised the price target on Pactiv Evergreen (NASDAQ: PTVE) to $13.00 (from $11.00) while maintaining a Outperform rating.
You May Also Be Interested In
- ADC Therapeutics (ADCT) PT Lowered to $5 at Guggenheim
- Enhanced Group Inc. (ENHA) PT Lowered to $5 at Canaccord
- AEON Biopharma, Inc (AEON) PT Lowered to $1.20 at H.C. Wainwright
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
